https://cluster-site.onrender.com/tags/commits/ Recent content in Commits on Tenu Tech Brief Hugo -- 0.146.0 en-us Wed, 25 Feb 2026 19:43:35 +0000 https://cluster-site.onrender.com/posts/require-pull-requests-for-all-circt-commits/ Wed, 25 Feb 2026 19:34:42 +0000 https://cluster-site.onrender.com/posts/require-pull-requests-for-all-circt-commits/ • Require Pull Requests for all CIRCT commits As discussed in the ODM today, we are going to follow LLVM’s policy of requiring GitHub pull requests for all commits to themainbranch https://cluster-site.onrender.com/posts/novo-nordisk-commits-up-to-2b-to-drug-delivery-startup-vivtex-for-rd-of-oral-metabolic-meds/ Wed, 25 Feb 2026 17:22:44 +0000 https://cluster-site.onrender.com/posts/novo-nordisk-commits-up-to-2b-to-drug-delivery-startup-vivtex-for-rd-of-oral-metabolic-meds/ • Vivtex’s technology uses AI and high throughput screening to identify the combinations of drug ingredients that can deliver peptides through gastrointestinal tissue • Besides Nov https://cluster-site.onrender.com/posts/novartis-commits-100m-to-startup-with-tech-that-brings-peptides-to-undruggable-targets/ Thu, 19 Feb 2026 20:47:39 +0000 https://cluster-site.onrender.com/posts/novartis-commits-100m-to-startup-with-tech-that-brings-peptides-to-undruggable-targets/ • Novartis’s alliance with Unnatural Products is pursuing next-generation peptide drugs for cardiovascular disease. • The startup already has drug R&D alliances with BridgeBio Phar https://cluster-site.onrender.com/posts/bambu-lab-discontinues-p1p-3d-printer-commits-to-support-through-2031/ Wed, 11 Feb 2026 17:40:00 +0000 https://cluster-site.onrender.com/posts/bambu-lab-discontinues-p1p-3d-printer-commits-to-support-through-2031/ • Bambu Lab has retired the venerable P1P 3D printer. • The P1P was quite popular for a time, as it was the lowest-price option in the P series. • Essentially a P1S without the enc